Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Blood Pressure Effects of Gender-Affirming Hormone Therapy in Transgender and Gender-Diverse Adults.

Literature DB >> 33866800

Blood Pressure Effects of Gender-Affirming Hormone Therapy in Transgender and Gender-Diverse Adults.

Katherine Banks¹, Mabel Kyinn¹, Shalem Y Leemaqz², Eleanor Sarkodie³, Deborah Goldstein³, Michael S Irwig^1,4.

Abstract

[Figure: see text].

Entities: Chemical

Keywords: adults; blood pressure; estrogen; hypertension; testosterone; transgender

Mesh：

Substances：
Estrogens
Testosterone

Year: 2021 PMID： 33866800 DOI： 10.1161/HYPERTENSIONAHA.120.16839

Source DB: PubMed Journal: Hypertension ISSN： 0194-911X Impact factor: 10.190

Keyword Cloud
Cited

8 in total

1. Characteristics of Transgender Women Referred to Women's Heart Clinic.

Authors: Madeline K Mahowald; Arvind K Maheshwari; Kyla M Lara-Breitinger; Fadi W Adel; Patricia A Pellikka; Caroline J Davidge-Pitts; Todd B Nippoldt; Birgit Kantor; Rekha Mankad
Journal: Am J Prev Cardiol Date: 2021-07-10

Review 2. Transgender Cardiovascular Health: Practical Management for the Clinician.

Authors: Caroline Ong; Minghao Liu; Sadiya Thermidor; Marwen Eid; Eugenia Gianos
Journal: Curr Atheroscler Rep Date: 2022-06-29 Impact factor: 5.967

3. Standards of Care for the Health of Transgender and Gender Diverse People, Version 8.

Authors: E Coleman; A E Radix; W P Bouman; G R Brown; A L C de Vries; M B Deutsch; R Ettner; L Fraser; M Goodman; J Green; A B Hancock; T W Johnson; D H Karasic; G A Knudson; S F Leibowitz; H F L Meyer-Bahlburg; S J Monstrey; J Motmans; L Nahata; T O Nieder; S L Reisner; C Richards; L S Schechter; V Tangpricha; A C Tishelman; M A A Van Trotsenburg; S Winter; K Ducheny; N J Adams; T M Adrián; L R Allen; D Azul; H Bagga; K Başar; D S Bathory; J J Belinky; D R Berg; J U Berli; R O Bluebond-Langner; M-B Bouman; M L Bowers; P J Brassard; J Byrne; L Capitán; C J Cargill; J M Carswell; S C Chang; G Chelvakumar; T Corneil; K B Dalke; G De Cuypere; E de Vries; M Den Heijer; A H Devor; C Dhejne; A D'Marco; E K Edmiston; L Edwards-Leeper; R Ehrbar; D Ehrensaft; J Eisfeld; E Elaut; L Erickson-Schroth; J L Feldman; A D Fisher; M M Garcia; L Gijs; S E Green; B P Hall; T L D Hardy; M S Irwig; L A Jacobs; A C Janssen; K Johnson; D T Klink; B P C Kreukels; L E Kuper; E J Kvach; M A Malouf; R Massey; T Mazur; C McLachlan; S D Morrison; S W Mosser; P M Neira; U Nygren; J M Oates; J Obedin-Maliver; G Pagkalos; J Patton; N Phanuphak; K Rachlin; T Reed; G N Rider; J Ristori; S Robbins-Cherry; S A Roberts; K A Rodriguez-Wallberg; S M Rosenthal; K Sabir; J D Safer; A I Scheim; L J Seal; T J Sehoole; K Spencer; C St Amand; T D Steensma; J F Strang; G B Taylor; K Tilleman; G G T'Sjoen; L N Vala; N M Van Mello; J F Veale; J A Vencill; B Vincent; L M Wesp; M A West; J Arcelus
Journal: Int J Transgend Health Date: 2022-09-06

4. Incidence of hypertension in young transgender people after a 5-year follow-up: association with gender-affirming hormonal therapy.

Authors: Francisco Javier Martinez-Martin; Agnieszka Kuzior; Alba Hernandez-Lazaro; Ricardo Jose de Leon-Durango; Carlos Rios-Gomez; Borja Santana-Ojeda; Jennifer Maria Perez-Rivero; Paula Maria Fernandez-Trujillo-Comenge; Paula Gonzalez-Diaz; Claudia Arnas-Leon; Carmen Acosta-Calero; Esperanza Perdomo-Herrera; Alba Lucia Tocino-Hernandez; Maria Del Sol Sanchez-Bacaicoa; Maria Del Pino Perez-Garcia
Journal: Hypertens Res Date: 2022-10-14 Impact factor: 5.528

5. Body, metabolic and renal changes following cross-sex estrogen/progestogen therapy in a rodent model simulating its use by transwomen.

Authors: J V Gusmão-Silva; D C K Lichtenecker; L G A Ferreira; Í Gois; R Argeri; G N Gomes; M R Dias-da-Silva
Journal: J Endocrinol Invest Date: 2022-06-11 Impact factor: 5.467

Blood Pressure Effects of Gender-Affirming Hormone Therapy in Transgender and Gender-Diverse Adults.

1. Characteristics of Transgender Women Referred to Women's Heart Clinic.

Review 2. Transgender Cardiovascular Health: Practical Management for the Clinician.

3. Standards of Care for the Health of Transgender and Gender Diverse People, Version 8.

4. Incidence of hypertension in young transgender people after a 5-year follow-up: association with gender-affirming hormonal therapy.

5. Body, metabolic and renal changes following cross-sex estrogen/progestogen therapy in a rodent model simulating its use by transwomen.

Review 6. Care of Gender Diverse Youth with Obesity.

Review 7. The Care of Transgender Young People.

8. Cardiovascular disease in transgender people: recent research and emerging evidence.